# Precision NanoSystems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/precision-nanosystems

- Industry: Biotechnology
- Headquarters: Vancouver, Canada
- Website: www.precisionnanosystems.com
- Total disclosed funding: $19M
- Latest round: Series B (May 17, 2018)
- Investors on record: 3

## About

Based in Vancouver, Canada, and founded in 2010, Precision NanoSystems Inc. provides medical tools and processes for medicines and medical research. The company was co-founded by James Taylor, Ph.D. as its CEO, and Euan Ramsay, Ph.D. as its Chief Comercial Officer.

The company provides NanoAssemblr™ transfection reagents that use nanomedicine technology to deliver genetic materials in primary cells in vitro and in vivo. The firm's NanoAssemblr™ platform allows the reproducible manufacture of nanoparticle formulations for the delivery of nucleic acids, drug molecules, and diagnostic agents to cells and tissues in the body.

## Funding rounds

- Series B, May 17, 2018, $6M — Telegraph Hill Partners, 5AM Ventures, Portfolia
- Series A, Sep 29, 2015, $13M — Telegraph Hill Partners, 5AM Ventures, Portfolia

## Investors

- Telegraph Hill Partners (https://capitalatlas.ai/funds/telegraph-hill-partners) — Series A, Series B
- 5AM Ventures (https://capitalatlas.ai/funds/5am-ventures) — Series A, Series B
- Portfolia (https://capitalatlas.ai/funds/portfolia) — Series A, Series B